StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Arrowhead Pharma (ARWR) Gains After Vertex Pharma (VRTX) Discontinues VX-814, Shares Up 15%
October 14, 2020 4:51 PM
Arrowhead Pharma (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Vertex Pharma (VRTX) has decided to stop dosing in trial and will discontinue development of VX-814
October 14, 2020 4:49 PM
Vertex Provides Update on its Clinical Programs Targeting Alpha-1 Antitrypsin Deficiency
October 14, 2020 4:30 PM
